CIK 0001863127 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831476348
- Phone
- (619) 728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- 4 Open-market buy Director bought 186,850 shares at $10.19 ($1,904,002)
- 4 Open-market buy Director bought 1,211,198 shares at an average $9.70 ($11,751,304)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 1,241 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,238 shares (grant or award)
- 4 Open-market sale Director sold 5,401 shares at $13.76 ($74,324)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 4,825 shares at $16.26 ($78,466)
- 4 Open-market sale Director sold 25,041 shares at an average $16.36 ($409,645)
- 4 Open-market sale Director sold 5,272 shares at $16.84 ($88,773)
- 4 Open-market buy Director bought 1,220,681 shares at $16.25 ($19,836,066)
- 4 Open-market sale Director sold 74,582 shares at an average $17.22 ($1,284,133)
- 4 Open-market sale Director sold 11,569 shares at an average $16.79 ($194,248)
Page 3 of 11 · 203 filings